New Compound, BIIB074, May Ease Trigeminal Neuralgia Pain with Fewer Side Effects, Study Says
Treatment with a compound called BIIB074 shows promise in reducing pain caused by trigeminal neuralgia — a  condition that occasionally affects…
Joana brings more than 8 years of academic research and experience as well as Scientific writing and editing to her role as a Science and Research writer. She also served as a Postdoctoral Researcher at the Center for Neuroscience and Cell Biology in Coimbra, Portugal, where she also received her PhD in Health Science and Technologies, with a specialty in Molecular and Cellular Biology.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Treatment with a compound called BIIB074 shows promise in reducing pain caused by trigeminal neuralgia — a  condition that occasionally affects…
Canadian researchers are testing mice to see if cannabinoid oil products — a common medical marijuana treatment — could help…
Gilenya (fingolimod)Â a multiple sclerosis (MS) drug developed to target the immune system and control inflammation, can also reduce the…
People with multiple sclerosis (MS) and other chronic diseases value the Affordable Care Act (ACA, also known as Obamacare) more…
Multiple sclerosis (MS) patients who are showing signs of cognitive impairment may benefit from computer-assisted cognitive rehabilitation programs, according to a…
MicroRNAs in the blood could serve as biomarkers to monitor the progression of multiple sclerosis (MS), as well as help…
Two multiple sclerosis (MS) patients developed severe brain inflammation after being treated with Lemtrada (alemtuzumab), researchers report, raising questions about…
Repeated magnetic stimulation of the brain may help to rebuild the brain’s network in patients with multiple sclerosis (MS), leading…
GeNeuro recently announced that it has finished enrolling multiple sclerosis (MS) patients in the CHANGE-MS Phase 2b  study —…
Healthcare providers frequently assess multiple sclerosis (MS) patients for the development of other health conditions, such as depression, anxiety, pain…
A number of important discoveries, therapeutic developments, and events related to multiple sclerosis (MS) were reported daily by Multiple Sclerosis News Today…
Lack of physical activity and a poor diet may be the most common risk factors for poor health and survival…
The U.S. Food and Drug Administration recently extended until the end of March its review of the Biologics License Application…
Researchers, using camels as an inspiration, have finally developed antibodies against a group of proteins known as metalloproteinases (MMPs), which…
Hemoglobin leaking from injured red blood cells may be associated with brain atrophy in secondary progressive multiple sclerosis (SPMS), according to…
Certain contrast agents used during magnetic resonance imaging (MRI) may accumulate in specific brain areas and contribute to disease duration…
Multiple sclerosis (MS) patients now taking part in a Phase 2b clinical trial testing the efficacy and safety of the antibody GNbAC1 will…
The risk of developing multiple sclerosis (MS) later in life may be higher for babies born with low levels of…
A new ways of delivering drug therapies directly to the brain, overcoming the limitation imposed by the blood-brain barrier (a permeable…
Researchers have found neural stem cells (immature cells that can become neurons) in the meninges of the brain, a three-layer…
The National Institutes of Health (NIH) awarded a $45,000 grant to a team of investigators, led by Tia Walker, PhD,…
Palliative care helps to ease the symptoms of serious illnesses, providing people with cancer and those with other life-altering diseases, like multiple sclerosis (MS) or cystic…
Voters in four U.S. states on Nov. 8 chose to legalize the recreational use of marijuana, and those in three other states…
In general, patients with multiple sclerosis (MS) choose their disease-modifying drug (DMD) treatment based on considerations of effectiveness and potential…
Despite recent studies showing that treatment with Ampyra (Fampyra in Europe; fampridine) improves both walking speed and ability, and offers…
A variant in the TYK2 gene, which encodes an immune system protein, may work to protect people from autoimmune disorders, including multiple sclerosis…
Results from a Phase 2 clinical trial showed that treatment with Ampyra (prolonged-release fampridine) brought both physical and psychological benefits to…
Multiple sclerosis (MS), especially in premenopausal women, does  not seem to be associated with breast cancer, as suggested in previous studies,…
Changes in the composition of certain immune system cells may be associated with relapses in multiple sclerosis (MS) patients being…
Damaging immune system defects seen in patients with multiple sclerosis (MS) can be repaired using a simple stem cell approach, according to…
Get regular updates to your inbox.